Advertisement
Skip to Content

CareDx Inc CDNA Stock Quote

| Rating as of

NASDAQ: CDNA

Last close prices updated as of Jan 31, 2023, 12:44 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 14.65
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Investment Style Small Growth
  • Day Range 14.64  –  15.21
  • Year Range 10.50  –  46.88
  • Market Cap 801.4532 Mil
  • Volume / Avg 104,871.0 /  1.1 Mil
  • Price / Sales 2.44
  • Price / Book 1.80
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis CDNA

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics CDNA

Company Profile CDNA

Business Description

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a leading provider of genomics-based information for transplant patients. Its primary operations are in Brisbane, California; Omaha, Nebraska; Fremantle, Australia and Stockholm, Sweden.

Contact
1 Tower Place, 9th Floor
South San Francisco, CA, 94080
Industry Diagnostics & Research
Employees 645

FAQs for CareDx Inc Stock

No. CDNA does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

CDNA’s market cap is 801.45 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

CDNA’s stock style is Small Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

CDNA’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare CDNA’s historical performance against its industry peers and the overall market.